Showing results (1-10 of 407) with videos related to
Sort By:
Pageof 41
Antiviral Research|September 7, 2000
Retroviral integrase inhibitors year 2000: update and perspectivesY Pommier, C Marchand, N NeamatiAdvances in Virus Research|June 29, 1999
Inhibitors of human immunodeficiency virus integraseY Pommier, N NeamatiBioorganic & Medicinal Chemistry Letters|March 4, 2000
Recognition and inhibition of HIV integrase by a novel dinucleotideM Taktakishvili, N Neamati, Y Pommier, et al.Bioorganic & Medicinal Chemistry Letters|May 30, 2001
Discovery of a nuclease-resistant, non-natural dinucleotide that inhibits HIV-1 integraseM Taktakishvili, N Neamati, Y Pommier, et al.Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Inhibition of HIV integrase by novel nucleotides bearing tricyclic basesJ Zhang, N Neamati, Y Pommier, et al.Methods in Molecular Medicine|February 19, 2011
Retroviral integrase : a novel target in antiviral drug development and basic in vitro assays with the purified enzymeA Mazumder, N Neamati, S Sunder, et al.The Journal of Biological Chemistry|November 1, 1996
Chemical trapping of ternary complexes of human immunodeficiency virus type 1 integrase, divalent metal, and DNA substrates containing an abasic site. Implications for the role of lysine 136 in DNA bindingA Mazumder, N Neamati, A A Pilon, et al.Molecular Pharmacology|January 13, 1998
Potent inhibitors of human immunodeficiency virus type 1 integrase: identification of a novel four-point pharmacophore and tetracyclines as novel inhibitorsN Neamati, H Hong, S Sunder, et al.Molecular Pharmacology|August 23, 2000
Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl estersW Pluymers, N Neamati, C Pannecouque, et al.Journal of Medicinal Chemistry|April 11, 1997
Arylamide inhibitors of HIV-1 integraseH Zhao, N Neamati, A Mazumder, et al.Pageof 41